Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study.
Vener C, Lillini R, De Angelis R, Bonfarnuzzo S, Poirel HA, Trama A, Visser O, Troussard X, Marcos-Gragera R, Maynadié M, Demuru E, Di Benedetto C, Johannesen TB, Solans M, Paapsi K, Guevara M, Mousavi SM, Blum M, Von Moos R, Bennett D, Ragusa R, Guilloteau A, McShane CM, Rossi S, Sant M; EUROCARE-6 Working Group (appendix pp 34-35).
Vener C, et al. Among authors: lillini r.
Eur J Cancer. 2025 May 2;220:115231. doi: 10.1016/j.ejca.2025.115231. Epub 2025 Jan 16.
Eur J Cancer. 2025.
PMID: 40056559